Tongue squamous cell carcinoma resists hyperthermia treatment by promoting Id-1 expression mediated EMT - 30/08/22
Le carcinome épidermoïde de la langue résiste au traitement par hyperthermie en favorisant l’expression de l’EMT par l’Id-1.
Summary |
Epithelial-mesenchymal transition (EMT) is a key initial step in the recurrence and metastasis of tongue squamous cell carcinoma (TSCC). Hyperthermia (HT) may reduce the rate of postoperative recurrence and distant metastasis by reversing the process of EMT of tumor cells, but the molecular mechanism is unclear. This study aims to investigate the role of inhibitor of differentiation/DNA binding-1 (Id-1) in HT mediated reversal of EMT of TSCC cells, and to provide a new approach for the treatment of TSCC using therapeutic gene targeting. After the combination of RNA interference with Id-1 and HT, the morphology of TSCC cells changed from spindle-like to pebble-like, and the arrangement of cells changed from loose and disorderly to compact and orderly. The silencing of Id-1 gene enhances the efficacy of HT by affecting the expression of EMT markers in TSCC cells. This study suggests that the Id-1 gene in TSCC cells can regulate transforming growth factor-beta 1, thereby affecting the expression of EMT markers, to achieve the effect of reducing HT.
Le texte complet de cet article est disponible en PDF.Keywords : Tongue Squamous Cell Carcinoma, Hyperthermia, Inhibitor of differentiation/DNA binding-1, Epithelial-mesenchymal transition, Transforming growth factor-beta 1
Plan
Vol 109 - N° 9
P. 886-894 - septembre 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?